Politi, M. C.
George, N.
Li, T.
Korenblat, K. M.
Fowler, K. J.
Ho, C.
Liapakis, A.
Roth, D.
Yee, J.
Funding for this research was provided by:
Merck
Article History
Received: 1 November 2017
Accepted: 14 February 2018
First Online: 21 February 2018
Ethics approval and consent to participate
: This study is approved by the Human Research Protection Office (HRPO) at Washington University in St. Louis protocol number 2017707154.
: Not Applicable.
: MCP has a research contract (2017–2019) funded by Merck & Co., Inc., Kenilworth, NJ, USA, and previously received a speaker fee from Merck & Co, Inc., Kenilworth, NJ, USA. KJF has recently consulted for Protalix, Hansa Medical, Horizon Pharma Inc., TapCloud LLC, and Merck & Co, Inc., Kenilworth, NJ, USA. DR has served on advisory boards for Bristol-Myers Squibb and Merck & Co, Inc., Kenilworth, NJ, USA. CH, AL, and JY consult for a research study funded by Merck & Co, Inc., Kenilworth, NJ, USA. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.